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ABSTRACT The self-association of proteins is influenced by amino acid sequence, molecular conformation, and the
presence of molecular additives. In the presence of phenolic additives, LysB28ProB29 insulin, in which the C-terminal prolyl
and lysyl residues of wild-type human insulin have been inverted, can be crystallized into forms resembling those of wild-type
insulins in which the protein exists as zinc-complexed hexamers organized into well-defined layers. We describe herein
tapping-mode atomic force microscopy (TMAFM) studies of single crystals of rhombohedral (R3) LysB28ProB29 that reveal the
influence of sequence variation on hexamer-hexamer association at the surface of actively growing crystals. Molecular scale
lattice images of these crystals were acquired in situ under growth conditions, enabling simultaneous identification of the
rhombohedral LysB28ProB29 crystal form, its orientation, and its dynamic growth characteristics. The ability to obtain
crystallographic parameters on multiple crystal faces with TMAFM confirmed that bovine and porcine insulins grown under
these conditions crystallized into the same space group as LysB28ProB29 (R3), enabling direct comparison of crystal growth
behavior and the influence of sequence variation. Real-time TMAFM revealed hexamer vacancies on the (001) terraces of
LysB28ProB29, and more rounded dislocation noses and larger terrace widths for actively growing screw dislocations
compared to wild-type bovine and porcine insulin crystals under identical conditions. This behavior is consistent with weaker
interhexamer attachment energies for LysB28ProB29 at active growth sites. Comparison of the single crystal x-ray structures
of wild-type insulins and LysB28ProB29 suggests that differences in protein conformation at the hexamer-hexamer interface
and accompanying changes in interhexamer bonding are responsible for this behavior. These studies demonstrate that subtle
changes in molecular conformation due to a single sequence inversion in a region critical for insulin self-association can have
a significant effect on the crystallization of proteins.
INTRODUCTION
Insulin is a small, 51-amino acid, dual-chain hormone pro-
duced in the pancreas that plays a crucial role in the main-
tenance of blood glucose levels. The inability to achieve
glucose homeostasis leads to the development of diabetes, a
chronic disease that often requires supplemental insulin in
the form of regular injections of either freely soluble insulin
or microcrystalline insulin suspensions. The efficacy of
such therapies strongly depends upon the dissociation of
insulin hexamers to the bioactive monomers (Hollenberg,
1990; Gammeltoft, 1988; Berson and Yalow, 1966; Smith et
al., 1984). In the case of microcrystalline insulin suspen-
sions, the efficacy is also influenced by the rate of crystal
dissolution, which depends on crystal structure (polymor-
phism), morphology, and size. However, numerous single
crystal structural investigations of insulin reveal that this
protein crystallizes as layers of hexamer units. This suggests
that a crucial first step in crystal dissolution is disruption of
the hexamer-hexamer interface at the crystal surface.
One approach to the development of insulin therapies
relies on controlling insulin self-association by specific alter-
ations to the sequence of wild-type human insulin (Brems et
al., 1992a,b; Brange et al., 1990, 1991). The synthesis of
LysB28ProB29, an insulin analog in which the prolyl and lysyl
residues at positions 28 and 29 in the B-chain of wild-type
human insulin are inverted, is illustrative of such efforts (Di-
Marchi et al., 1992; Long et al., 1992; Howey et al., 1994).
This minor sequence inversion, which occurs in the region of
the insulin B-chain known to be involved in dimer formation,
yields a bioactive insulin analog whose self-association equi-
libria are shifted strongly toward the monomer, in contrast to
the wild types that exist predominantly as hexamers. Never-
theless, recent x-ray diffraction studies performed on single
crystals of LysB28ProB29 grown in the presence of phenol,
which was required for isolation of x-ray quality crystals,
revealed that the LysB28ProB29 monomers assemble as zinc-
complexed hexamers, despite the reduced association constant
of the hexamer (Ciszak et al., 1995).
The phenolic additives apparently stabilize the
LysB28ProB29 hexamer so that crystallization, via self-as-
sembly of hexamer units, can occur. The dissolution char-
acteristics of crystalline forms of LysB28ProB29 will depend
upon the detachment of hexamers from exposed crystal
surfaces, typically at high surface energy sites such as steps
and kinks. Consequently, the role of the sequence inversion
and accompanying conformational perturbation to hexamer-
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hexamer self-association in the crystal needs to be eluci-
dated. This requires direct experimental observation of phe-
nomena related to hexamer-hexamer association coupled
with analysis of the hexamer-hexamer interface. This
prompted us to examine the structure and growth charac-
teristics of LysB28ProB29 crystals with real-time in situ
atomic force microscopy (AFM). Several recent investiga-
tions have demonstrated that AFM is ideal for examining
crystallization, at the near-molecular level, of small-mole-
cule organic crystals (Manne et al., 1993; Last and Ward,
1996; Hillier and Ward, 1994; Hillier et al., 1994; Carter et
al., 1994; Mao et al., 1997) and protein crystals (Ng et al.,
1997; Yip and Ward, 1996; McPherson et al., 1996;
Kuznetsov et al., 1996; Land et al., 1995, 1996; Malkin et
al., 1995; Konnert et al., 1994; Durbin et al., 1993; Durbin
and Carlson, 1992). This method enables direct assignment
of the crystal planes under investigation, observation of
defects, characterization of the topography (i.e., steps,
ledges, kinks) of actively growing faces, determination of
the influence of additives on topography, and measurement
of crystallization rates along specific crystallographic direc-
tions. We describe herein AFM investigations that reveal
differences in specific crystal growth characteristics of
LysB28ProB29 and wild-type insulins that reflect weaker
interhexamer interactions in the former. Comparison of the
crystal structures of the two forms reveals differences in
conformation and intermolecular interactions at the hex-
amer-hexamer interface that may be responsible for this
behavior. These observations are quite remarkable in that
they illustrate the extent to which a single sequence inver-
sion can perturb the delicate noncovalent interactions re-
sponsible for hexamer-hexamer association at the crystal
surface, and the influence of the perturbations on crystal
growth, crystal dissolution, and crystal quality. Further-
more, these results illustrate that AFM performed on crystal
surfaces can provide direct insight into the nature of insulin
self-association in different crystalline formulations, which
is crucial for elucidating the therapeutic efficacy of the
treatment of diabetes.
MATERIALS AND METHODS
Crystals of LysB28ProB29 insulin were prepared by the following procedure,
which has been described previously (Ciszak et al., 1995). To a precleaned
20-ml glass scintillation vial containing 10 mg of LysB28ProB29 (Eli Lilly
and Company) was added 5 ml of 0.02 M HCl. After gentle swirling to
dissolve the LysB28ProB29, 12 l of aqueous 20 weight % ZnCl2, 16.5 l
of aqueous 90 weight % phenol, and 2 ml of 0.2 M sodium citrate buffer
were added sequentially to afford a slightly turbid solution. After adjusting
the pH of the solution to 5.7, the solution was heated gently to 50°C in
a water bath to afford a clear solution. Slow cooling of this solution to room
temperature over several days afforded well-defined micron-sized crystals.
Crystals of recombinant human and purified bovine and porcine insulins
(Eli Lilly and Company) were prepared under identical conditions.
Solution tapping-mode AFM (TMAFM) images were acquired with a
Digital Instruments Nanoscope III MultiMode scanning probe microscope
with a combination contact/tapping-mode liquid cell (Digital Instruments,
Santa Barbara, CA). All images were acquired using 120-m oxide-
sharpened silicon nitride V-shaped cantilevers with integral bipyramidal
tips (type DNP-S; Digital Instruments). Before use, the AFM tips were
exposed to UV irradiation to remove adventitious organic contaminants
from the tip surface. It should be noted that tapping-mode operation in
solution employs cantilevers with a lower spring constant than is typically
employed for tapping mode in air, to compensate for viscous coupling
between the cantilever and surrounding fluid that increases the effective
spring constant of the cantilever. AFM images were acquired using a
scanning head with a maximum lateral scan area of 14.6 m  14.6 m.
The crystals to be examined were transferred via pipette into a well formed
by an O-ring affixed to an AFM sample mount coated with a thin layer of
vacuum grease. The lateral translation of the AFM tip is restricted by the
O-ring in this configuration, thereby hampering the positioning of the tip
on a sample region of interest. Consequently, it was important to devise a
procedure that enabled reliable positioning of the tip on an insulin crystal.
This was accomplished by mounting the cantilever into the body of the
AFM liquid cell and aligning the laser spot on the cantilever tip without a
sample present. The liquid cell then was removed from the AFM optical
head and replaced with the AFM sample mount to which the crystals were
affixed. Without adjusting the laser spot positioning screws and while
monitoring the position of the laser spot through an optical microscope, the
AFM optical head was translated in the x-y plane until the laser spot was
located above a crystal of interest. The liquid cell body containing the
inserted cantilever tip was then reseated over the O-ring. This procedure
also reduced sample creep arising from relaxation of the O-ring.
Stable images were acquired at cantilever drive frequencies ranging
from 6 to 30 kHz, but imaging was optimal at frequencies near 8.9 kHz.
However, a priori determination of the appropriate drive frequency was
difficult, owing to viscous coupling between the cantilever and the fluid
medium, which gave rise to multiple broad resonance peaks. The range and
selection of optimal imaging drive frequencies were somewhat dependent
on the particular cantilever, sample surface, and solution conditions. The
cantilever drive voltage and setpoint imaging voltage significantly influ-
enced image quality and sample integrity, and occasional slight departures
from optimum values resulted in sample etching. Accordingly, feedback
conditions were selected based on optimization of image quality. Data
analyses were performed on low-pass filtered AFM images, using Nano-
scope III (version 4.22b1; Digital Instruments) and National Institutes of
Health Image (version 1.61) software packages. National Institutes
of Health Image is available by anonymous file transfer protocol from
zippy.nimh.nih.gov.
RESULTS AND DISCUSSION
Crystallographic characterization by AFM
The LysB28ProB29 insulin molecule differs from its human,
bovine, and porcine wild-type analogs by a sequence inver-
sion of the proline and lysine residues at positions 28 and 29
in the C-terminus of the B-chain, and substitution of alanine
for threonine in the case of bovine and porcine insulin
(Table 1). Using established procedures, crystals of
LysB28ProB29 were grown from solution as the rhombohe-
dral form (Ciszak et al., 1995). Under identical growth
conditions, crystals of wild-type human, bovine, and por-
cine insulins grew as thick rectangular plates. The crystal
structures have been reported for wild-type human and
TABLE 1 Comparison of the sequence in the C-terminus of
the B-chain for wild-type and LysB28ProB29 insulins
Residue number: 23 24 25 26 27 28 29 30
Human: Gly Phe Phe Tyr Thr Pro Lys Thr
Bovine/porcine: Gly Phe Phe Tyr Thr Pro Lys Ala
LysB28ProB29: Gly Phe Phe Tyr Thr Lys Pro Thr
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porcine insulins, but the structures of crystals grown under
the conditions used here are unknown (although it is un-
likely that the crystal structures would be dramatically af-
fected by these conditions).
Tapping mode AFM (TMAFM) images of the largest
face of the LysB28ProB29 single crystals were acquired di-
rectly in the crystallization liquor. The tapping mode (Han-
sma et al., 1994) was used because conventional contact
mode caused significant etching of the crystal surfaces. The
AFM images of this face revealed large, molecularly
smooth, micron-sized terraces decorated by steps with
heights of 30 Å. This step height is similar to the value of
the c lattice constant of rhombohedral LysB28ProB29 (space
group R3, a  b  79.62 Å, c  37.78 Å,   120°, as
indexed on hexagonal axes). This suggested that the imaged
face was (001), which, based on single crystal x-ray dif-
fraction (Ciszak et al., 1995), can be described as a corru-
gated layer of insulin hexamers arranged in a hexagonal
motif. The 30-Å step heights observed by AFM were some-
what smaller than expected, based on the c lattice constant.
This may be due to differences in solvation between
LysB28ProB29 hexamer layers at the crystal-solution inter-
face and in the bulk crystal. The assignment of this face as
(001) was confirmed by TMAFM images acquired in the
crystallization liquor over a smaller region of the face.
These images revealed molecular-level contrast of a nomi-
nally hexagonal 2-D lattice (Fig. 1) with 2-D lattice con-
stants, as determined from the real space AFM data and the
corresponding two-dimensional Fourier power spectrum,
a1  43.4 Å  4 Å, a2  48.5 Å  4 Å, a3  52.0 Å  5
Å, 12  53.3°, and 23  68.1°. The averages of these
values (a1  48.0 Å; 12  60.8°) are in good agreement
with the symmetry and periodicity expected (a1  46.0 Å
and 12 60°) for the hexagonal arrangement of the insulin
hexamers when viewed normal to the (001) plane, as de-
picted in Fig. 1 B. The slight departure of the AFM data
from a perfect hexagonal arrangement can be attributed to
intrinsic measurement error. The 46-Å a1 lattice constant
(equivalent to a2 and a3) represents the separation between
hexamers along the close-packed directions in the (001)
plane. Close inspection of the lattice images acquired on
adjacent terraces separated by steps revealed excellent
translational and rotational registry between overlying (001)
layers, indicating the structural order required for good
crystal quality. This confirms the R3 rhombohedral phase,
in which the hexagonal arrays are stacked in registry along
the c axis.
The single crystal x-ray structures of human, bovine, and
porcine insulins prepared under the conditions described in
Materials and Methods have not been reported. To compare
the crystal growth characteristics of the R3 LysB28ProB29
insulin with other wild types, it was important to verify that
FIGURE 1 (A) Real space TMAFM lattice image, obtained in situ during crystallization, for the (001) crystal plane of LysB28ProB29. Scan size  100
nm  100 nm; scan rate  4.36 Hz. Raw and Fourier filtered data are displayed in the upper right and lower left regions of the image. The hexagonal
symmetry apparent in this data corresponds to the arrangement of insulin hexamers in the (001) plane. (Inset) The two-dimensional Fourier power spectrum
corresponding to the AFM data. The reciprocal lattice vectors describe a hexagonal 2-D lattice with a1  43.4 Å; a2  48.5 Å; a3  52.0 Å; 12  53.3°;
23  68.1°, as depicted here by the alternative hexagonal lattice. The average of these values (a1  48.0 Å; 12  60.8°) is in good agreement with the
nearest neighbor hexamer separation (a1  46.0 Å) and the hexagonal symmetry of the (001) layers (  60°). The real space vectors a1, a2, and a3 define
the nearest neighbor packing of the hexamers. The arrows on the raw data in A indicate vacancies in the (001) crystal plane corresponding to missing
LysB28ProB29 hexamers. (B) The LysB28ProB29 hexamer packing motif of the (001) plane based on single crystal x-ray diffraction. The rhombohedral unit
cell used for the structure solution is depicted by the solid black lines, with a  b  79.62 Å and c  37.78 Å, indexed on hexagonal axes. The structural
model in B was prepared with Cerius2 version 2.0 (Molecular Simulations, San Diego, CA), using coordinates registered with the Brookhaven Protein Data
Bank as pdb1lph.ent.
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the wild-type crystalline forms grown under these condi-
tions crystallized in the same space group as LysB28ProB29.
Notably, 65% of the insulin structures for which space
groups have been assigned in the Brookhaven Protein Da-
tabase belong to the R3 space group, compared to only 2%
of all crystal structures in the Database (Abola et al., 1987;
Bernstein et al., 1977). Indeed, the R3 space group was
corroborated for bovine insulin crystals by lattice images
acquired with in situ TMAFM on single crystals that were
tilted so that crystallographically different adjoining faces
were accessible to the TMAFM tip in a single experiment
(Fig. 2 A). TMAFM images acquired on the large terraces of
the screw dislocation in region 1 of Fig. 2 A exhibited
nominally hexagonal symmetry, with a1  43 Å  4 Å and
  62°  4°, in good agreement with the values expected
for the (001) crystal plane of the R3 insulin. In contrast,
images acquired on the large terraces of the screw disloca-
tion in region 2 afforded a monoclinic lattice with a1 33.5
Å  3 Å, a2  45.1 Å  4 Å, and   60°  3°. These
values are in good agreement with those expected for the
monoclinic arrangement of insulin hexamers on the (110)
plane of the rhombohedral cell used for structure solution,
for which values of a1  37.8 Å, a2  47.7 Å, and   61°
are expected. Attempts to obtain molecular-scale lattice
images on porcine insulin grown under the same conditions
were not successful, owing to the difficulties in locating a
properly oriented crystal. However, the (001) lattice images,
surface features, and morphology of the porcine crystals
determined by AFM were identical to those of the bovine
and LysB28ProB29 insulin crystals. This argues that all three
insulins grown under these conditions crystallized in the R3
space group. These results demonstrate the crystallographic
capabilities of in situ AFM with respect to screening pos-
sible space group symmetries for protein crystals that have
not been characterized by single-crystal x-ray diffraction.
Crystal defects
The TMAFM images revealed numerous vacancies on the
LysB28ProB29 (001) terraces that were not present on the
wild-type bovine, porcine, and human insulin crystals.
These vacancies exhibited sizes corresponding to the ab-
sence of single hexamers or multiples of hexamers (Fig. 1
A). The defects were stable on the AFM time scale, and
additional ones were not formed upon prolonged scanning,
indicating that their formation was not a consequence of the
tapping-mode imaging process. Although detection of sin-
FIGURE 2 (A) In situ AFM tapping mode image acquired across the intersection of three crystal faces of a bovine insulin crystal grown under the same
conditions as used for crystallization of LysB28ProB29 insulin. Scan size 5 m 5 m; scan rate 2.00 Hz. Well-defined screw dislocations are evident.
(B) Lattice images acquired in region 1 and (C) in region 2. Scan size: 25 nm  25 nm; scan rate: 2.00 Hz. The two-dimensional unit cells, determined
from the respective Fourier power spectra, are outlined in black. The hexagonal lattice in region 1 and the monoclinic lattice in region 2 are consistent with
the arrangement of insulin hexamers on the (001) and (110) planes of the R3 rhombohedral cell. Experimental lattice parameters: region 1: a1  43 Å 
4 Å;   62°  4°; region 2: a1  33.5 Å  3 Å; a2  45.1 Å  4 Å;   60°  3°. Expected values based on R3 LysB28ProB29 insulin: (001): a1 
46.0 Å Å;   60°; (110): a1  37.8 Å; a2  47.7 Å;   61°.
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gle atomic- or molecular-scale defects generally is difficult
owing to the ensemble imaging mechanism of the AFM, in
the case of LysB28ProB29, a single hexamer defect would be
5 nm in diameter, which is within the resolution limits of
the TMAFM.
Sampling of numerous (001) LysB28ProB29 crystal ter-
races revealed that the defect density was 1010 cm2,
which was several orders of magnitude larger than values
reported for other protein systems such as thaumatin (104-
106 defects  cm2) (Malkin et al. 1996). It has been sug-
gested that the requirement of phenolic additives for the
crystallization of LysB28ProB29 and the absence of directed
bonding interactions from the conformationally flexible N-
terminal regions of the B-chain in the interhexamer contact
region are evidence of weaker interhexamer interactions for
LysB28ProB29 compared to the wild-type insulin forms
(Bakaysa et al., 1996; Birnbaum et al., 1997; Ciszak et al.,
1995). This argues that the point defects are due to detach-
ment of hexamers from the crystal surface layer. Vacancy
formation during growth is also possible. As the monomer-
monomer association constant for LysB28ProB29 is signifi-
cantly lower than for wild-type human insulin, with corre-
spondingly lower equilibrium constants for higher even-
order aggregates (Brems et al., 1992a), nonspecific
attachment of subhexamer aggregates to the growing crystal
surfaces may induce vacancy formation.
Our AFM studies also revealed random features on the
(001) terraces of the LysB28ProB29 and the wild-type insulin
crystals that are similar to features observed on bovine
insulin in a previous study in our laboratory (Yip and Ward,
1996). The dimensions of these features were 20 nm 
10 nm  2.5 nm. These were presumed to be insulin
aggregates that have attached to the surface after formation
in solution or aggregates formed by Ostwald ripening on the
crystal surface. The former is supported by previous studies
that have confirmed the presence of insulin aggregates in
solution before crystallization (Milthorpe et al., 1977; Bo-
hinder and Geissler, 1984; Pederson et al., 1994; Jeffrey,
1974; Hvidt, 1991). We have not observed any evidence for
diffusion of these aggregates along the surface to an actively
growing step on the time scale of our AFM imaging. The
poor mobility of the large aggregates actually instigates the
formation of macroscopic defects such as dislocation cores
and voids in individual terraces (see box, Fig. 3, D–F).
Advancing steps grew around the aggregate, leaving a de-
pletion zone between the aggregate and the step edge. An
examination of numerous LysB28ProB29 and wild-type insu-
lin single crystals by tapping-mode AFM in solution re-
vealed similar voids at the center of several screw disloca-
tions, suggesting that these aggregates may initiate screw
dislocations. Similar behavior has been reported previously
(Yip and Ward, 1996; Malkin et al., 1996; Land et al.,
1996). The persistence of these defects contrasts with the
repair of large surface defects formed by mechanical etch-
ing with the AFM tip. Repair of these defects occurred at a
rate comparable to that of step advancement, with volume
growth rates of 1.1  106 m3  s1 and 2  106
m3  s1, respectively (volume growth rates were used for
comparison purposes because the mechanically etched re-
gion was nominally three molecular layers deep, whereas
the screw dislocation and terrace expansion regions com-
prised only single molecular terraces). These growth rates
correspond to the attachment of approximately five unit
cells (15 LysB28ProB29 hexamers) per second. Growth in the
etched region occurred by expansion of individual terrace
edges, with the lowest terraces filling first. These data
suggest well-ordered repair of the surface via attachment of
FIGURE 3 (A–F) In situ real-time
solution tapping mode AFM images of
the (001) plane of a LysB28ProB29 sin-
gle crystal. Images were acquired at (A)
0, (B) 3605, (C) 7210, (D) 10,815, (E)
18,025, and (F) 40,590 s. Scan size 
5 m  5 m; scan rate  2.00 Hz.
The rectangular area marked A corre-
sponds to a region that was mechani-
cally etched by the AFM tip during
imaging. The screw dislocation com-
pletes a rotation during the image se-
quence. The etched region refills
within 120 min to generate a fully re-
paired terrace surface. In D, a protein
aggregate, outlined by a white box, has
attached to the crystal surface. In E and
F, this aggregate has not been incorpo-
rated into the growing step edge, but
rather instigates the formation of a de-
pletion zone that creates a persistent
defect in the (001) layer.
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hexamers to the advancing step edges and the absence of
large aggregates on the terraces that would impede growth.
Crystal growth, including protein crystal growth, pre-
dominantly occurs by either two-dimensional nucleation or
screw dislocation-driven growth. The prominent crystal
faces of both the LysB28ProB29 and wild-type insulins ex-
hibited well-defined screw dislocations under the conditions
employed here. Real-time in situ TMAFM on the (001)
plane revealed layer-by-layer growth in which the layers
were spawned from the screw dislocations (Fig. 3). Inter-
estingly, this contrasts with previous studies of bovine in-
sulin crystal growth under different conditions (Yip and
Ward, 1996), in which screw dislocations were never ob-
served. This demonstrates that screw dislocation density can
be very sensitive to growth conditions. It is also important
to note that we did not observe tip-induced nucleation or
enhanced crystal growth within the imaged region that may
result from increased convection in the immediate vicinity
of the imaging region (LaGraff and Gewirth, 1994, 1995;
Land et al., 1996). This argues that crystal growth is dictated
by surface diffusion to the growing step edge, as opposed to
bulk volume diffusion to the crystal-solution interface (Yip
and Ward, 1996). The crystal structures of both the wild-
type and the LysB28ProB29 insulins indicate that the hexamer
is the basic structural unit, which argues that the hexamer is
the fundamental growth unit attaching to steps on the (001)
face (Kadima et al., 1991; Baker et al., 1988). Preliminary
light scattering data acquired in our laboratory during
LysB28ProB29 crystallization are also consistent with this
view.
Complex interlinked screw dislocations were observed
occasionally on the LysB28ProB29 and wild-type human,
bovine, and porcine insulin crystals (Fig. 4). One such
complex dislocation on the (001) surface of a porcine insu-
lin single crystal featured both left- and right-handed screw
dislocations that can be described as a Frank-Read disloca-
tion loop (Fig. 4 A). These data illustrate the correspondence
of the screw dislocations crystal structure and bulk crystal
morphologies. The intersecting steps subtend an angle of
125°, in good agreement with the 120° angle subtended by
the [110] and [11 0] directions, which define the nearest-
neighbor interhexamer contacts.
Comparison of the screw dislocations on actively grow-
ing (001) faces of LysB28ProB29, porcine, and bovine crys-
tals reveals obvious differences in the curvature of the
dislocation noses (i.e., the region of intersection of two
steps) and in the terrace widths (which correspond to the
ledge wavelength, 1). Specifically, the terrace widths and
nose curvature are significantly larger for LysB28ProB29 than
for porcine and bovine insulin. These topographical fea-
tures, which represent the nanoscale origins of the bulk
crystal habit, stem from differences in surface energies and
attachment free energies at the relevant crystal planes
(Tiller, 1991, 1992). The nose radius of curvature (rc),
which is equivalent to the critical nuclei radius of a stable
two-dimensional nucleus, is related to the surface energy of
the dislocation ledge (l) and the free energy of attachment
at the kink sites on the ledges of the dislocation (Gk)
according to Eq. 1, and is related to l according to Eq. 2:
rc
1
Gk
(1)
1 4rc 4
1
Gk
(2)
A rounded dislocation nose is the consequence of rough
ledges (i.e., many kinks) and slow growth parallel to the
ledge. Large values of l will favor rough ledges and large
terraces, because the overall surface energy will be reduced
by reducing the total area of the step planes parallel to the
ledge. Small values of Gk are synonymous with low sur-
face energies for the kink sites, which will favor the forma-
tion of these kink sites and roughening of the ledges. Sim-
ilarly, large terrace widths (large l) will be favored by
small Gk values, as the relative growth rate along the ledge
direction will be smaller. Conversely, for a given l, the net
effect of a large Gk is a screw dislocation with linear step
edges and sharp corners. This is the behavior observed for
the porcine insulin crystals (Fig. 3 F) and for the bovine
crystals (not shown). In contrast, a larger radius of curvature
and the development of capes and protrusions at the edges
of the screw dislocation were observed for LysB28ProB29,
indicating a smaller Gk and/or a larger l compared to
porcine insulin (Fig. 3 E). Smaller Gk values would be
consistent with weaker interhexamer interactions, which has
already been suggested as the source of the point defects
described above.
The cohesive energies and the attachment energies for the
LysB28ProB29 and the wild-type insulin crystals will be
governed by solvent and noncovalent interactions in the
region of interhexamer contact. The nature and availability
of these interactions will be influenced by the conformation
of the six monomer subunits of each hexamer, particularly
by the sequences in the interhexamer contact region. The
insulin monomer can adopt one of three conformations. In
the T and R states, the residues B1–B8 (of the N-terminus
of the B-chain) are in extended and -helical conformations,
respectively (Kaarsholm et al., 1989). In the “frayed” -he-
lix or Rf monomer state, the -helix region is shorter, as
residues B1 through B3 exist in an extended state (Ciszak et
al., 1995). The LysB28ProB29 hexamer, which comprises
three monomers in the T-state and three in the Rf state, can
be described as a T3R3f hexamer.
The primary sequence differences for the wild-type hu-
man, bovine, and porcine insulins, and LysB28ProB29 insulin
exist in the C-terminus of the B-chain (Table 1). To evaluate
the effect of these sequence variations on interhexamer
contacts, we compared the hexamer packing motifs in
LysB28ProB29 (Brookhaven Protein Data Bank entry code:
pdb1lph.ent) with the T3R3f human insulin structure
(pdb1trz.ent; Ciszak and Smith, 1994) and the T6 2-Zn
porcine insulin structure (pdb4ins.ent), all of which belong
to the R3 space group. The interhexamer contact region of
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T6 2-Zn porcine insulin structure contains a combination of
ionic, aromatic, and hydrogen-bonding forces (Baker et al.,
1988). The majority of the hydrogen bonding interactions
are solvent-mediated; however, a strong directional hydro-
gen bond exists between ThrB27 OH and AspA18 NH of
neighboring hexamers. The T6 2-Zn porcine hexamers are
stabilized further by aromatic interactions arising from the
PheB1 and TyrA14 residues of one hexamer interacting with
the TyrA19 residues of a neighboring hexamer. These aro-
matic interactions will depend upon the conformation of the
monomer (R- or T-state). In the T6 hexamer state, all of the
B1 Phe residues are situated on the periphery of the hex-
amer perpendicular to the crystallographic c axis. However,
in the T3R3f hexamer, three of the B1 Phe residues are
positioned toward the middle of the hexamer, making these
less available for lateral interhexamer interaction and caus-
ing a reduction in the in-plane attachment energy associated
with the growth of the (001) hexamer layers (Fig. 5).
In the T3R3f structure, the -carbon carboxylate of the
ThrB30 residue of one hexamer interacts with the guanidine
side group of the ArgB22 residue of a neighboring hexamer.
Although not a direct interaction, solvent may serve to
stabilize this interface between the ThrB30 and ArgB22 res-
idues of neighboring hexamers. Careful examination of the
FIGURE 4 (A) In situ TMAFM
image acquired during crystallization
that illustrates a Frank-Read disloca-
tion loop on the (001) crystal plane of
a porcine insulin crystal grown under
the conditions described in Materials
and Methods. Scan size  1.5 m 
1.5 m; scan rate  2.0 Hz. The step
height is 38 Å. (B) Schematic rep-
resentation of aggregate addition to a
kink site on an exposed crystal ter-
race. The ledge interfacial energy and
the free energy of kink addition are
denoted by l and Gk, respectively.
The width of the individual ledge
sites is denoted by l. (C and D)
Schematic representations of (C)
rounded and (D) sharp screw disloca-
tions. The magnified regions illus-
trate that roughened ledges with nu-
merous kink sites afford rounded
dislocations, whereas smooth ledges
with few kinks afford sharp disloca-
tions. (E and F) Screw dislocations
observed by in situ TMAFM under
identical conditions of (E) R3
LysB28ProB29 and (F) R3 porcine in-
sulin crystals. Scan size  5 m  5
m; scan rate 2.0 Hz. The rounded
dislocations in E signify small Gk
values, which are synonymous with
the low surface energy for the kink
planes that favors their formation.
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molecular models of T3R3f wild-type human insulin and
T3R3f LysB28ProB29 hexamers revealed significant differ-
ences only in the B28 through B30 domains (Fig. 5). No-
tably, the LysB28ProB29 sequence restricts the free reorien-
tation of the terminal ThrB30 residue, so that the ThrB30
group of LysB28ProB29 is bent away from the hexamer-
hexamer contact region and resides in a relatively large
solvent pocket between adjacent LysB28ProB29 hexamers.
We note that the x-ray structure refinement for
LysB28ProB29 yielded large thermal factors for the B29 and
FIGURE 5 (A) Molecular model of the LysB28ProB29 hexamer packing motif in the (001) crystal plane. Only those residues involved in hexamer-hexamer
contact are shown. Residues located in the middle of the hexamer rings project out of the page, and are involved in hexamer-hexamer contact with the
overlying (001) crystal plane. (Inset) Ribbon model of LysB28ProB29 dimer. The models were prepared using Quanta96 (Molecular Simulations, San Diego,
CA). The white outline defines the region of interhexamer contact. (B) Schematic model of interhexamer contacts within a hexagonal (001). The black
outline corresponds to the white outline in A.
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FIGURE 6 Molecular models of the LysB28ProB29 and human insulin T3R3f structure. (A and B) Models of the C-terminal B-chain B27-B30 residues of
(A) human insulin and (B) LysB28ProB29. Because of large thermal parameters, some of the side-chain residues (e.g., lysine) were not located. (C and D)
Models of the B22 Arg-B30 Thr interhexamer contacts between three neighboring hexamers of (C) human insulin and (D) LysB28ProB29. The B22 Arg and
B28-B30 residues are shown as ball-and-stick models. The dashed lines indicate distances between the carboxylate group of the B30 Thr and the guanidine
side group of the B22 Arg side chain located in the adjacent hexamer. The models were prepared with Quanta96, using coordinates registered with the
Brookhaven Protein Data Bank as pdb1trz.ent (human insulin T3R3f ) and pdb1lph.ent (LysB28ProB29).
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B30 residues (G. D. Smith, personal communication), con-
sistent with less restricted motion in the large pocket. In the
human T3R3f structure, the separation distance between
neighboring ThrB30 and the ArgB22 groups of adjacent hex-
amers is 4 Å, whereas this separation approaches 7 Å in
the LysB28ProB29 T3R3f structure, (Fig. 6, C–D). It is rea-
sonable to conclude that these factors will cumulatively
reduce the interhexamer interaction energy in the (001)
plane, thereby leading to reduced Gk values that are evi-
dent from the rounded dislocation noses.
CONCLUSIONS
The studies described above provide direct insight into the
influence of experimental conditions and the LysB28ProB29
sequence inversion on crystal growth characteristics. The
bovine insulin crystals were characterized by a large num-
ber of screw and slip dislocations, in contrast with earlier
AFM studies in our laboratory, in which crystal growth
occurred through expansion of large (1 m) terraces
emerging from undetectable growth centers (Yip and Ward,
1996). The crystallization conditions of this earlier work
(pH 6.5–8.5, and lower concentrations of phenol) differed
from those used in the present study, indicating that the
crystallization medium and additives directly influence the
density of screw dislocations and the structure of the solu-
tion-crystal interface.
The most remarkable observation in these studies is the
substantial change in crystal growth behavior resulting from
the sequence inversion at the C-terminus of the B-chain.
Although the comparisons made here were for LysB28ProB29
and wild-type porcine/bovine insulins that have different
C-terminal residues (Thr versus Ala, respectively), the con-
siderable difference in the self-association behaviors of hu-
man and LysB28ProB29 insulin, which both have Thr resi-
dues at the C-terminus, suggests that the sequence inversion
is principally responsible for the behavior observed by
AFM. Comparison of the LysB28ProB29 and wild-type insu-
lin crystal structures suggests that the sequence inversion
reduces interhexamer interactions in LysB28ProB29, which
results in a smaller attachment energy (Gk) and, conse-
quently, more rounded screw dislocations and large terrace
widths. The formation of persistent vacancies in the (001)
surface planes of actively growing crystals, which can result
in inclusions that affect crystal quality, also can be attrib-
uted to reduced lateral interhexamer interaction. These stud-
ies demonstrate that subtle alterations in a protein sequence,
designed to address a specific need such as a reduction in
insulin monomer association, can influence the self-assem-
bly into the crystalline solid state, which may (or may not)
be desirable. Such considerations have significant implica-
tions for the development of novel therapeutic formulations
based on crystalline protein forms.
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